FDB MEDKNOWLEDGE Descriptive and Pricing, Foundations, and Drug Pricing

Amendment 005 issued to extend the response due date and to advise that the SF1449 and amendments 001, 002, 003, 004, and 005 does not require offeror signature.

Amendment 004 issued to extend the response due date and to advise that the SF1449, and amendments 001, 002, 003, and 004 does not require offeror signature.

Amendment 003 issued to extend the response due date and to advise that the SF1449, 001, 002, and 003 does not require offeror signature.

Amendment 002 issued to extend the response due date and to advise that the SF1449, 001, and 002 does not require offeror signature.

Amendment 001 issued to extend the response due date.

The DLA Troop Support Medical Directorate has a requirement to renew its current data subscription licence agreement for FDB MEDKNOWLEDGE Descriptive & Pricing, Foundations, and Drug Pricing, This will be a full & open procurement for a brand-name data subscription renewal in support of DLA Troop Support Medical Directorate. The anticipated Period of Performance (PoP) is for a twelve (12) month base period with performance to begin 01 June 2023 through 31 May 2024, and the resultant award will include two (2) twelve (12) month option periods. Please see the attachments for further details. This requirement is supported by a brand name Justification & Approval. Only First Data Bank, Inc., the Original Equipment Manafucture (OEM), certified and authorized resellers or dealers can provide the required support.